✦ LIBER ✦

Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women

✍ Scribed by F Conradie; C Zorrilla; D Josipovic; M Botes; O Osiyemi; E Vandeloise; T Eley; M Child; R Bertz; W Hu; V Wirtz; D McGrath

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness and safety of saquinavir/r

✍ C. Brunet; V. Reliquet; T. Jovelin; N. Venisse; N. Winer; E. Bui; G. Le Moal; P. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 French ⚖ 283 KB

Influence of tenofovir, nevirapine and e

✍ Eric Dailly; Olivier Tribut; Pierre Tattevin; Cédric Arvieux; Philippe Perré; Fr 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 90 KB

Once-daily atazanavir/ritonavir versus t

✍ Jean-Michel Molina; Jaime Andrade-Villanueva; Juan Echevarria; Ploenchan Chetcho 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 246 KB

Efficacy of dual therapy with lamivudine

✍ Casado, J. L.; Banon, S.; Rodriguez, M. A.; Santiuste, C.; Perez-Elias, M. J.; M 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 127 KB

Limited sampling strategies for the esti

✍ Dario Cattaneo; Diego Ripamonti; Sara Baldelli; Valeria Cozzi; Serena Fucile; Em 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 385 KB

Safety and pharmacokinetics of etravirin

✍ P Izurieta; TN Kakuda; C Feys; J Witek 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB